Eli Lilly hikes sales outlook, as CEO says there's room for 'dramatic' obesity market expansion
🕑 1 min read
Eli Lilly reported that sales of obesity drug Zepbound and diabetes treatment Mounjaro surged again in the third quarter.
Source: Business News — Read the original story
